(精编)【高血压精品英文课件】肾性高血压 Hypertension in Nephrology.pptVIP

Hypertension in NEPHROLOGY; ;Parallels Between Hypertension in 1972 and Kidney Disease in 2005;RENAL INJURY;Walking the dog;MAJOR RISK FACTORS FOR CARDIOVASCULAR DISEASE;Why are CKD/ESRD Patients Predisposed to CV Disease?;Why are CKD/ESRD Patients Predisposed to CV Disease?;Microalbuminuria and proteinuria as a risk factor for CAD and CVA – marker of endovascular health;Prevalence of HTN in CKD;0;Relative risk of ESRD according to quintile BP;Hypertension in CKD;Concept of Glomerular Hypertension;GFR Proteinuria Aldosterone release Glomerular sclerosis;Renin Angiotensin Aldosterone System;PGC;PGC;PGC;Angiotensin II and CKD;Angiotensin II ;A II Blockade – Experimental datawith diabetic rats at 70 weeks;Treatment to Prevent Progression of CKD to Kidney Failure; Treatment goal for hypertension in the general population has remained relatively the same for the last decade.;For Individuals With:;Should be lower than the general population Should be tailored according to : ;Aggressive BP Control, Proteinuria and CKD Progression – what is the optimal BP for CKD?;Steps every clinician should take to reduce the incidence and/or progression of CKD Aggressive BP reduction Use of agents that interfere with the RAAS;BP control, GFR decline and proteinuria;Progression of CKD and BP;Continued ramipril;AASK: ACEI vs CCB in Hypertensive Renal Disease;Cardiovascular mortality;The Effect of Angiotensin-Converting Enzyme Inhibition on Diabetic Nephropathy;ACE Inhibition and Type I DM Nephropathy;Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan – RENAAL ;RENAAL – ARB Reduction of Renal Failure ;Irbesarten Diabetic Nephropathy Trial (IDNT) ;IDNT – ARB Reduction of Renal Failure ; ARB Effects of Type II DM Nephropathy - RENAAL and IDNT;ACE Inhibitors and CKD ProgressionMeta-analysis -Jafar T, Ann Intern Med 135:73-87, 2001;Proportion of Patients With First Event, %;Patients; non-diabetic patients affected by proteinuric renal disease MAP ?98 mmHg Treatme